(EXO) Exor - Ratings and Ratios
Cars, Trucks, Tractors, Buses, Ferrari
EXO EPS (Earnings per Share)
EXO Revenue
Description: EXO Exor October 14, 2025
Exor N.V. (AS:EXO) is a diversified holding company that controls leading brands across automotive, industrial, media, and sports sectors, including Ferrari, Stellantis, CNH Industrial, Iveco Group, Juventus FC, and GEDI. Its portfolio spans luxury sports cars, mass-market vehicles, agricultural and construction equipment, powertrain technologies, diagnostic imaging, clean-energy solutions, and a suite of media properties.
Key economic drivers for Exor’s core segments are the global shift toward electrification (which is accelerating demand for EV models within Stellantis and powertrain upgrades for CNH Industrial), cyclical construction spending (affecting CNH Industrial and Iveco’s equipment sales), and discretionary consumer spending (impacting Ferrari’s premium-pricing power). As of FY 2023, Ferrari posted €4.2 bn in revenue with a 12% operating margin, while Stellantis reported a 6% year-over-year increase in EV deliveries, now representing roughly 15% of its total volume.
From a valuation perspective, Exor benefits from a low-beta, high-cash-flow profile: the conglomerate generated €9.5 bn of operating cash flow in 2023, and its diversified earnings reduce exposure to any single market downturn. However, the company’s exposure to interest-rate-sensitive financing services and to cyclical sectors such as construction equipment introduces downside risk if macro-economic conditions deteriorate.
For a deeper quantitative breakdown of Exor’s exposure to these trends, the ValueRay platform offers a granular, data-driven view.
EXO Stock Overview
| Market Cap in USD | 28,725m |
| Sub-Industry | Automobile Manufacturers |
| IPO / Inception |
EXO Stock Ratings
| Growth Rating | -15.2% |
| Fundamental | 74.7% |
| Dividend Rating | 41.4% |
| Return 12m vs S&P 500 | -36.3% |
| Analyst Rating | - |
EXO Dividends
| Dividend Yield 12m | 0.66% |
| Yield on Cost 5y | 0.75% |
| Annual Growth 5y | 4.55% |
| Payout Consistency | 100.0% |
| Payout Ratio | 0.7% |
EXO Growth Ratios
| Growth Correlation 3m | -80.9% |
| Growth Correlation 12m | -68.7% |
| Growth Correlation 5y | 57% |
| CAGR 5y | 0.44% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.02 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.05 |
| Sharpe Ratio 12m | -0.18 |
| Alpha | -30.13 |
| Beta | 0.398 |
| Volatility | 23.73% |
| Current Volume | 159.1k |
| Average Volume 20d | 196.4k |
| Stop Loss | 72 (-3.1%) |
| Signal | -0.94 |
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (4.19b TTM) > 0 and > 6% of Revenue (6% = 2.68b TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 5.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.67% (prev 36.97%; Δ -38.64pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 6.25b > Net Income 4.19b (YES >=105%, WARN >=100%) |
| Net Debt (1.97b) to EBITDA (6.43b) ratio: 0.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (201.5m) change vs 12m ago -10.50% (target <= -2.0% for YES) |
| Gross Margin 25.27% (prev 22.72%; Δ 2.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 66.39% (prev 44.15%; Δ 22.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 46.80 (EBITDA TTM 6.43b / Interest Expense TTM 113.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.17
| (A) -0.02 = (Total Current Assets 339.0m - Total Current Liabilities 1.09b) / Total Assets 40.00b |
| (B) -0.02 = Retained Earnings (Balance) -624.0m / Total Assets 40.00b |
| (C) 0.08 = EBIT TTM 5.29b / Avg Total Assets 67.39b |
| (D) -0.17 = Book Value of Equity -624.0m / Total Liabilities 3.64b |
| Total Rating: 0.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.70
| 1. Piotroski 9.0pt = 4.0 |
| 2. FCF Yield 12.50% = 5.0 |
| 3. FCF Margin 7.68% = 1.92 |
| 4. Debt/Equity 0.11 = 2.49 |
| 5. Debt/Ebitda 0.31 = 2.43 |
| 6. ROIC - WACC (= 3.08)% = 3.85 |
| 7. RoE 12.32% = 1.03 |
| 8. Rev. Trend 89.52% = 6.71 |
| 9. EPS Trend -54.60% = -2.73 |
What is the price of EXO shares?
Over the past week, the price has changed by -4.01%, over one month by -14.60%, over three months by -11.28% and over the past year by -22.68%.
Is Exor a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXO is around 61.40 EUR . This means that EXO is currently overvalued and has a potential downside of -17.36%.
Is EXO a buy, sell or hold?
What are the forecasts/targets for the EXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117.7 | 58.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 67.4 | -9.3% |
EXO Fundamental Data Overview January 01, 1970
Market Cap EUR = 24.92b (24.92b EUR * 1.0 EUR.EUR)
P/S = 1.7692
P/B = 0.4822
Beta = 0.398
Revenue TTM = 44.74b EUR
EBIT TTM = 5.29b EUR
EBITDA TTM = 6.43b EUR
Long Term Debt = 3.04b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.05b EUR (from shortLongTermDebt, last fiscal year)
Debt = 4.09b EUR (Calculated: Short Term 1.05b + Long Term 3.04b)
Net Debt = 1.97b EUR (from netDebt column, last quarter)
Enterprise Value = 27.48b EUR (24.92b + Debt 4.09b - CCE 1.53b)
Interest Coverage Ratio = 46.80 (Ebit TTM 5.29b / Interest Expense TTM 113.0m)
FCF Yield = 12.50% (FCF TTM 3.44b / Enterprise Value 27.48b)
FCF Margin = 7.68% (FCF TTM 3.44b / Revenue TTM 44.74b)
Net Margin = 9.37% (Net Income TTM 4.19b / Revenue TTM 44.74b)
Gross Margin = 25.27% ((Revenue TTM 44.74b - Cost of Revenue TTM 33.43b) / Revenue TTM)
Gross Margin QoQ = 24.75% (prev 24.75%)
Tobins Q-Ratio = 0.69 (Enterprise Value 27.48b / Total Assets 40.00b)
Interest Expense / Debt = 2.76% (Interest Expense 113.0m / Debt 4.09b)
Taxrate = 12.89% (243.5m / 1.89b)
NOPAT = 4.61b (EBIT 5.29b * (1 - 12.89%))
Current Ratio = 0.31 (Total Current Assets 339.0m / Total Current Liabilities 1.09b)
Debt / Equity = 0.11 (Debt 4.09b / totalStockholderEquity, last quarter 36.35b)
Debt / EBITDA = 0.31 (Net Debt 1.97b / EBITDA 6.43b)
Debt / FCF = 0.57 (Net Debt 1.97b / FCF TTM 3.44b)
Total Stockholder Equity = 34.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.49% (Net Income 4.19b / Total Assets 40.00b)
RoE = 12.32% (Net Income TTM 4.19b / Total Stockholder Equity 34.04b)
RoCE = 14.26% (EBIT 5.29b / Capital Employed (Equity 34.04b + L.T.Debt 3.04b))
RoIC = 9.84% (NOPAT 4.61b / Invested Capital 46.80b)
WACC = 6.77% (E(24.92b)/V(29.01b) * Re(7.48%) + D(4.09b)/V(29.01b) * Rd(2.76%) * (1-Tc(0.13)))
Discount Rate = 7.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 3.71%
[DCF Debug] Terminal Value 72.13% ; FCFE base≈3.05b ; Y1≈2.16b ; Y5≈1.15b
Fair Price DCF = 109.5 (DCF Value 22.06b / Shares Outstanding 201.5m; 5y FCF grow -34.29% → 3.0% )
EPS Correlation: -54.60 | EPS CAGR: -91.16% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.52 | Revenue CAGR: 15.97% | SUE: 1.13 | # QB: 1